Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Candel Therapeutics, Inc. (CADL)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.2100-0.0300 (-0.93%)
At close: 04:00PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 6/28/2022
Current
3/31/202212/31/20219/30/2021
Market Cap (intraday)
100.14M146.04M224.35M311.00M
Enterprise Value
28.61M63.96M136.51M287.20M
Trailing P/E
N/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/A
Price/Sales (ttm)
801.11768.511.79k2.15k
Price/Book (mrq)
1.572.283.56N/A
Enterprise Value/Revenue
228.882.06k4.40k9.26k
Enterprise Value/EBITDA
-0.90-119.7776.48-17.81

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-54.14%
S&P500 52-Week Change 3-11.93%
52 Week High 314.7800
52 Week Low 33.0000
50-Day Moving Average 33.7114
200-Day Moving Average 36.4218

Share Statistics

Avg Vol (3 month) 344.57k
Avg Vol (10 day) 37.56k
Shares Outstanding 528.69M
Implied Shares Outstanding 6N/A
Float 812.4M
% Held by Insiders 133.48%
% Held by Institutions 123.39%
Shares Short (Jun 14, 2022) 464.19k
Short Ratio (Jun 14, 2022) 43.1
Short % of Float (Jun 14, 2022) 40.36%
Short % of Shares Outstanding (Jun 14, 2022) 40.22%
Shares Short (prior month May 12, 2022) 460.25k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-23,601.60%

Management Effectiveness

Return on Assets (ttm)-26.99%
Return on Equity (ttm)-76.23%

Income Statement

Revenue (ttm)125k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)0.00%
Gross Profit (ttm)125k
EBITDA -29.13M
Net Income Avi to Common (ttm)-32.52M
Diluted EPS (ttm)-1.4060
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)94.32M
Total Cash Per Share (mrq)3.29
Total Debt (mrq)22.79M
Total Debt/Equity (mrq)35.74
Current Ratio (mrq)17.48
Book Value Per Share (mrq)2.22

Cash Flow Statement

Operating Cash Flow (ttm)-24.64M
Levered Free Cash Flow (ttm)-17.92M
Advertisement
Advertisement